Boston has reported its lowest number of overdose deaths in a decade, according to new data released in June 2025. The significant decline in overdose fatalities highlights the success of recent public health initiatives aimed at combating the opioid crisis that has plagued the city. Experts credit a combination of increased availability of naloxone, community outreach programs, and enhanced support services for those struggling with addiction. The Boston Public Health Commission’s strategic focus on harm reduction and prevention has been pivotal in achieving this milestone. City officials are optimistic about continuing this trend, emphasizing the importance of sustained efforts and resources to maintain and improve these promising results. Residents and health advocates alike are hopeful that Boston can serve as a model for other cities battling similar challenges.
WBURNew data shows CLYM116 reduces key IgA nephropathy biomarkers by ~70%, supporting a 12-week dosing regimen
October 24, 2026
New data released by CLIMB Bio and MabWorks reveals that their investigational drug CLYM116 significantly reduces critical biomarkers associated with IgA nephropathy by approximately 70%.